Does INTERFERON BETA-1B Cause Thrombotic microangiopathy? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Thrombotic microangiopathy have been filed in association with INTERFERON BETA-1B (Betaseron). This represents 0.2% of all adverse event reports for INTERFERON BETA-1B.
21
Reports of Thrombotic microangiopathy with INTERFERON BETA-1B
0.2%
of all INTERFERON BETA-1B reports
0
Deaths
13
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From INTERFERON BETA-1B?
Of the 21 reports, 13 (61.9%) required hospitalization, and 4 (19.0%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
Yes, Thrombotic microangiopathy is listed as a known adverse reaction in the official FDA drug label for INTERFERON BETA-1B.
What Other Side Effects Does INTERFERON BETA-1B Cause?
Multiple sclerosis relapse (1,229)
Influenza like illness (1,042)
Injection site pain (1,014)
Fatigue (783)
Drug ineffective (767)
Injection site erythema (724)
Injection site reaction (707)
Pain (597)
Headache (596)
Multiple sclerosis (589)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
Which INTERFERON BETA-1B Alternatives Have Lower Thrombotic microangiopathy Risk?
INTERFERON BETA-1B vs INTERFERON GAMMA
INTERFERON BETA-1B vs INTERFERON GAMMA-1B
INTERFERON BETA-1B vs INVEGA
INTERFERON BETA-1B vs INVEGA SUSTENNA
INTERFERON BETA-1B vs INVESTIGATIONAL BIOSIMILARS